SARS News and Research

RSS

Investigating the zoonotic adaptation and anthropozoonotic transmission of SARS-CoV-2

Researchers summarize the possible causes and routes of transmission of SARS-CoV-2 between humans and animals.

2 Dec 2021

New bioinformatics method for viral sgRNA analysis

A recent study discusses a bioinformatics method to help identify and explore sgRNAs uncovered in next-generation sequencing data.

2 Dec 2021

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.

2 Dec 2021

Impact of SARS-CoV-2 infection on testis function

A study published in the journal Nature Reviews Urology discusses the impact of coronavirus disease 2019 (COVID-19) on male fertility.

2 Dec 2021

New insights offered into cell-to-cell propagation of SARS-CoV-2

Evidence from a new study supports previous findings showing SARS-CoV-2 particles inside host cells are morphologically identical to those outside of cells.

2 Dec 2021

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Scientists have mined information from several research publications and patents to create a dataset of approximately 8000 human antibodies to the SARS-CoV-2 spike from more than 200 donors.

2 Dec 2021

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

A new study has focussed on assessing the Mpro mutants of newly emerged SARS-CoV-2 variants.

2 Dec 2021

Preventing SARS-CoV-2 transmission at large indoor events

A new trial showed that indoor live events are not associated with an increased risk of SARS-CoV-2 infection, provided preventive interventions are in place.

2 Dec 2021

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Researchers from Academia Sinica in Taiwan have been investigating new antibodies that could have strong effects against SARS-CoV-2 infection.

2 Dec 2021

Novel method for estimating the ability of SARS-CoV-2 to spread in a population

Researchers from Curtin University have formulated a new modeling framework to help identify the transmissibility of COVID-19 based on periods of varying case incidence.

2 Dec 2021

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

In new studies, researchers concluded that licorice triterpenoids could be candidates for anti-SARS-CoV-2 drug developments.

2 Dec 2021

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Things that are freeze-dried: Astronaut food. Emergency rations. And, just maybe, some future COVID-19 vaccines.

1 Dec 2021

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

A recent study describes the association between time elapsed since the second dose of the Pfizer-BioNTech BNT162b2 vaccine and risk of COVID-19.

1 Dec 2021

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

Researchers review critically evaluated the transmission dynamics of SARS-CoV-2 across various ages in metropolitan France.

1 Dec 2021

Novel set of immune cells may have the opposite effect in multiple sclerosis, other brain conditions

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.

1 Dec 2021

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.

1 Dec 2021

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

New research suggests that a fourth dose of the mRNA-1273 vaccine in kidney transplant recipients improves Delta variant serum neutralization.

1 Dec 2021

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

A new study retrospectively estimates the effective transmission advantage of the Alpha variant as compared to other non-VOC lineages.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

Safety and immunogenicity of different COVID-19 booster vaccines

New study findings suggest that booster vaccination with an mRNA-based vaccine has the highest immunogenicity against the COVID-19 Delta variant.

1 Dec 2021

SARS News and Research

Investigating the zoonotic adaptation and anthropozoonotic transmission of SARS-CoV-2

New bioinformatics method for viral sgRNA analysis

Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil

Impact of SARS-CoV-2 infection on testis function

New insights offered into cell-to-cell propagation of SARS-CoV-2

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

Preventing SARS-CoV-2 transmission at large indoor events

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Novel method for estimating the ability of SARS-CoV-2 to spread in a population

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Freeze-dried liposomes could be used in potential COVID-19 vaccines

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

Novel set of immune cells may have the opposite effect in multiple sclerosis, other brain conditions

Impact of engineered ACE2-Fc on SARS-CoV-2 infection

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

Safety and immunogenicity of different COVID-19 booster vaccines

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News